Clinical Trials Logo
  1. Home
  2. High Cholesterol
  3. NCT04964544

Technology-Assisted Cholesterol Trial in Consumers (TACTiC) — TACTiC  

High Cholesterol Clinical Trial

Official title:
A Phase III, 6-Month Self-selection and Actual Use Study for Rx-to-OTC Switch of Rosuvastatin 5 mg Once-daily in Combination With a Web App

Clinical Trial Summary

The purpose of this AUS is to evaluate the extent to which participants can safely and effectively self-select, purchase, and use Crestor OTC 5 mg for a 6-month period according to the label.

Clinical Trial Description

This is a single-arm, interventional, phase III Self-Selection (SS) and Actual Use Study (AUS) using a technology assisted tool within a Web App. The open-label study will enroll approximately 1220 participants who qualify for treatment based on the data they enter into the Web App of which an estimated 1000 participants will ultimately proceed to the use phase. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04964544
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 3
Start date July 8, 2021
Completion date March 1, 2023
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00965055 - Ezetimibe in Patients Hypo-responsive to Statins Phase 3
Completed NCT03542240 - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome N/A
Recruiting NCT06192251 - Complete Lifestyle Medicine Intervention Program
Completed NCT01004237 - Additive Effects of Pravastatin and Valsartan Phase 4
Completed NCT01187056 - The RISAP-study: a Complex Intervention in Risk Communication and Shared Decision-making in General Practice N/A
Completed NCT06227819 - BVA-200 vs BVA-100 Validation Study
Completed NCT05266586 - Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy Phase 2
Completed NCT03084822 - Cardiovascular Health Promotion Among African-Americans by FAITH! N/A
Completed NCT04317690 - Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey
Completed NCT04317274 - Online Trial Examining Validity of the Shared Decision Making Process Survey With Video Vignettes N/A
Recruiting NCT06005597 - Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies Phase 3
Withdrawn NCT04510844 - Evolocumab In Advanced Chronic Kidney Disease Trial Phase 4
Completed NCT05421078 - A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy. Phase 2
Completed NCT03528031 - Habitual Diet and Avocado Trial N/A
Active, not recruiting NCT05425745 - Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. Phase 3
Completed NCT00833976 - Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia Phase 4
Completed NCT00510809 - Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy N/A
Terminated NCT04154579 - Arts & Health Education to Improve Health, Resilience, and Well-Being N/A
Recruiting NCT06350604 - Project WHADE: A Partner-Based Physical Activity Program for Women N/A
Not yet recruiting NCT05473325 - Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)